Premium
The pathogenesis of microthrombi in COVID‐19 cannot be controlled by DOAC: NETosis should be the target
Author(s) -
Gremese E.,
Ferraccioli G.
Publication year - 2021
Publication title -
journal of internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.625
H-Index - 160
eISSN - 1365-2796
pISSN - 0954-6820
DOI - 10.1111/joim.13228
Subject(s) - thrombotic microangiopathy , medicine , ards , pathogenesis , autopsy , coagulopathy , pathophysiology , d dimer , microangiopathy , thrombomodulin , endothelial activation , immunology , pathology , gastroenterology , lung , disease , inflammation , diabetes mellitus , platelet , endocrinology , thrombin
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom